State Street Corp Exelixis, Inc. Call Options Transaction History
State Street Corp
- $2.41 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding EXEL
# of Institutions
503Shares Held
244MCall Options Held
2.54MPut Options Held
2.29M-
Black Rock Inc. New York, NY33.5MShares$1.13 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.3MShares$986 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA25.4MShares$855 Million3.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.4MShares$517 Million0.63% of portfolio
-
Lsv Asset Management Chicago, IL8.1MShares$273 Million0.45% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $10.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...